MDQ screening focuses on possible manic or hypomanic symptom history
The Mood Disorder Questionnaire, often abbreviated as MDQ, is a patient-rated screening tool used to identify clients who may need further evaluation for bipolar spectrum disorders. It is not a diagnostic interview. It does not establish bipolar I disorder, bipolar II disorder, cyclothymic disorder, or any other diagnosis by itself. Its clinical value is in helping clinicians organize reported mood symptoms, functional impact, and follow-up assessment needs.
The MDQ was developed and validated as a screening instrument for bipolar spectrum disorder and is commonly described as a brief, patient-rated questionnaire for bipolar disorder screening [source:1], [source:2]. In practice, it can help a clinician notice patterns that may otherwise be missed when a client presents with depression, irritability, sleep disruption, impulsivity, or relationship conflict.
This distinction matters for documentation. A note should not say, “MDQ confirms bipolar disorder.” A more accurate statement would be, “Client completed MDQ; responses suggest possible history of manic/hypomanic symptoms and indicate need for further clinical assessment.” That wording preserves clinical accuracy and leaves room for diagnostic evaluation, differential diagnosis, and clinical judgment.
What the MDQ measures in clinical terms
The MDQ asks about a history of manic or hypomanic symptoms, whether symptoms occurred during the same period, and whether they caused problems in functioning. The commonly used version includes 13 yes/no symptom items, followed by questions about symptom clustering and level of impairment [source:3].
The symptom items address experiences that may occur during manic or hypomanic episodes, such as elevated or irritable mood, increased energy, decreased need for sleep, racing thoughts, distractibility, increased talkativeness, increased activity, and risky or impulsive behavior. Bipolar disorder can involve episodes of mania, hypomania, and depression, with changes in mood, energy, activity level, concentration, and functioning [source:4].
For documentation, it is often useful to separate the MDQ findings into three categories:
- Endorsed symptoms: Which manic or hypomanic-type symptoms the client reported on the questionnaire.
- Timing pattern: Whether the client reported that symptoms occurred during the same period.
- Functional impact: Whether the client reported that symptoms caused problems such as relationship strain, work disruption, financial consequences, or safety concerns.
The MDQ does not replace a full mood disorder assessment. A full evaluation may include clinical interview, mental status exam, symptom timeline, family history, substance use assessment, medication history, sleep patterns, trauma history, medical contributors, and review of prior episodes. Guidelines for bipolar disorder assessment emphasize careful clinical evaluation, including symptom history, functional impairment, risk, differential diagnosis, and comorbidities [source:7].
When clinicians commonly use the MDQ
Clinicians often use the MDQ when a client reports depression but also describes periods of unusually increased energy, reduced need for sleep, impulsive decisions, irritability, or rapid shifts in functioning. This can be especially relevant during intake, diagnostic clarification, treatment planning, or referral coordination.
Common situations include:
- Initial intake: A new client reports recurrent depressive episodes, mood swings, or a family history of bipolar disorder.
- Diagnostic clarification: A client has been treated for depression, but the symptom history suggests possible hypomanic or manic episodes.
- Treatment planning: Screening results indicate the need to gather more detail before finalizing goals, interventions, or referrals.
- Care coordination: A therapist documents screening findings to support referral to a psychiatrist, primary care clinician, or higher level of care when clinically indicated.
The MDQ may also be used when a client describes episodic impairment that does not fit neatly into a depressive, anxiety, trauma-related, or personality-focused formulation. For example, a client may report three-day periods of sleeping two hours per night while feeling highly energized, starting multiple projects, spending impulsively, and later feeling embarrassed or depressed. The MDQ can provide a structured way to capture those reported symptoms and guide the next clinical questions.
How MDQ results may inform documentation
MDQ results can support clinical documentation by creating a clear record of why additional mood assessment is being pursued. The results may also inform a clinician’s diagnostic impressions, treatment plan updates, safety assessment, referral rationale, and client education. The key is to document the result as screening information, not as a confirmed diagnosis.
For example, if a client endorses multiple symptoms and reports that they occurred during the same period with moderate impairment, the note might document that the MDQ was positive or clinically significant according to the version used, followed by the clinician’s plan for further assessment. If the client endorses only a few symptoms and reports no impairment, the note can still record the result and explain that bipolar spectrum symptoms were screened and not strongly indicated by the tool.
Documentation should connect the MDQ to the session. A screening result without context can feel disconnected from clinical care. A stronger note explains why the MDQ was used, what the client reported, how the clinician followed up, and what will happen next.
Clinically useful details to include
A concise MDQ note entry may include the following:
- Reason for screening: Depression history, mood instability, decreased sleep, family history, impulsivity, or diagnostic clarification.
- Client-reported result: Number or pattern of endorsed symptoms, if available and appropriate for your documentation workflow.
- Clinical follow-up: Questions asked about episode duration, impairment, substances, medication, medical factors, psychosis, or safety.
- Plan: Further assessment, monitoring, referral, psychiatric consultation, treatment plan revision, or psychoeducation.
Clinicians should also document relevant negatives when they are clinically meaningful. For instance, if the client denied decreased need for sleep, psychotic symptoms, risky behavior, or current safety concerns, those details may help clarify the assessment picture. Bipolar disorder evaluation often requires attention to both mood elevation symptoms and depressive episodes, as well as associated impairment and risk [source:6].
Documentation language that avoids overstating conclusions
MDQ documentation should be precise. The safest clinical language is usually descriptive rather than conclusive. Instead of writing that the MDQ “diagnosed” bipolar disorder, document what occurred: the client completed a screening tool, endorsed certain symptoms, discussed related history, and agreed to next steps.
Use phrases such as:
- “MDQ administered as a screening measure for possible bipolar spectrum symptoms.”
- “Client endorsed symptoms associated with possible hypomanic/manic episodes; further assessment indicated.”
- “Screening results were reviewed with client and will be considered alongside clinical interview and history.”
- “No diagnosis was made based solely on screening results.”
Avoid language that makes the tool sound stronger than it is. The MDQ is a screen. It can support clinical decision-making, but diagnosis requires broader assessment. The National Institute of Mental Health describes bipolar disorder as involving distinct mood episodes and changes in energy, activity, and concentration, which reinforces why a symptom checklist alone is not enough for diagnosis [source:4].
Sample MDQ documentation entry
The example below is not a required format. It shows how a clinician might document MDQ-related information in a progress note while keeping the interpretation appropriately limited.
Example: SOAP-style documentation
Subjective: Client reported recurrent depressive episodes and intermittent periods of increased energy, reduced need for sleep, rapid speech, and impulsive spending. Client stated these periods “usually last a few days” and have contributed to relationship conflict and missed work deadlines. Client denied current suicidal intent or plan.
Objective: Client completed the Mood Disorder Questionnaire during session as a screening measure for possible bipolar spectrum symptoms. Client endorsed multiple manic/hypomanic-type symptoms and reported that some symptoms occurred during the same period with moderate functional impact. Affect was mildly anxious; speech was normal rate during session; thought process was linear.
Assessment: MDQ results suggest need for further assessment of possible bipolar spectrum symptoms. Screening result is not diagnostic. Differential considerations include bipolar spectrum disorder, recurrent major depressive disorder with anxiety, trauma-related mood reactivity, substance/medication effects, and sleep-related contributors. No acute safety concerns reported or observed during session.
Plan: Continue mood episode timeline at next session, including duration, impairment, sleep changes, family psychiatric history, substance use, and prior medication response. Provide psychoeducation on mood tracking and sleep routine. Discuss psychiatric referral options if further assessment supports need for medication evaluation or diagnostic clarification.
This example documents the screening result, the client’s reported symptoms, the clinician’s interpretation, and the next clinical step. It does not treat the MDQ as a stand-alone diagnostic conclusion.
Common MDQ documentation mistakes
Many documentation problems come from using language that is too broad, too certain, or too disconnected from the clinical encounter. The MDQ can be helpful, but the note should show how the clinician used the information.
Mistake 1: Treating a positive screen as a diagnosis
A positive screen should be documented as an indication for further evaluation, not proof of bipolar disorder. Better wording: “Positive MDQ screen; further assessment of manic/hypomanic episodes indicated.” This is more accurate than “Client has bipolar disorder based on MDQ.”
Mistake 2: Omitting functional impairment
Symptoms matter, but impairment adds clinical meaning. If the client reports increased energy and reduced sleep, document whether those symptoms affected work, relationships, finances, safety, judgment, or daily responsibilities. The MDQ includes attention to whether symptoms caused problems, which helps place endorsed symptoms in context [source:3].
Mistake 3: Leaving out the reason for screening
A note that says only “MDQ completed” does not explain the clinical rationale. Include the reason the tool was used, such as mood instability, recurrent depression, family history, or treatment planning. This helps future readers understand why the screening was clinically relevant.
Mistake 4: Failing to document follow-up questions
Endorsed symptoms should usually lead to clarifying questions. Ask about episode duration, baseline functioning, sleep, substances, antidepressant exposure, psychosis, hospitalization, risky behavior, and safety. Document the follow-up that occurred, even briefly.
Mistake 5: Copying raw results without clinical context
Raw screening data can be useful, but it should not replace a clinical note. A stronger entry explains how the result fits with the client’s presentation, history, and plan. This is especially important when symptoms overlap with anxiety, ADHD, trauma responses, substance use, sleep deprivation, or medical conditions.
How MDQ findings fit into treatment planning
MDQ findings may influence treatment planning by identifying areas that need closer assessment before goals and interventions are finalized. For example, a clinician may decide to add mood tracking, sleep monitoring, psychiatric referral discussion, family history review, or psychoeducation about mood episodes.
For clients already in therapy, MDQ results may lead to a treatment plan update. The clinician might add objectives related to recognizing early warning signs, reducing impulsive behavior, improving sleep consistency, or increasing use of coping skills during periods of elevated energy or irritability. If risk concerns are present, the plan may also include safety planning or coordination with other providers.
Clinical guidelines for bipolar disorder management emphasize assessment, risk evaluation, monitoring, psychological interventions, and coordinated care when appropriate [source:7]. Documentation should reflect the clinician’s scope of practice and the next reasonable step, rather than presenting the MDQ as a final answer.
Practical MDQ documentation checklist
Before finalizing a note that includes MDQ-related information, review whether the entry answers the clinical questions another provider might have later.
- Did the note state why the MDQ was used?
- Did it describe the result as a screening result?
- Did it include relevant client-reported symptoms and impairment?
- Did it document follow-up assessment or next steps?
If the answer to any item is no, the note may need one or two additional sentences. This does not mean the note must be long. A concise, accurate entry is usually better than a lengthy note that overstates the meaning of the screening result.
How AutoNotes supports assessment-related documentation
AutoNotes helps clinicians create structured, editable progress note drafts from clinical details they provide. For MDQ-related sessions, that can include the reason for screening, client-reported symptoms, functional concerns, follow-up questions, clinical impressions, and next steps. The clinician remains responsible for reviewing, editing, and finalizing the note.
AutoNotes does not need to be positioned as the tool that administers, scores, diagnoses, or interprets the MDQ. Its role is documentation support. After a clinician completes an assessment-related discussion, AutoNotes can help organize the information into a note format such as SOAP, DAP, intake documentation, assessment summary, or treatment plan language.
For example, a therapist could enter session details such as: “Client completed MDQ due to recurrent depression and periods of decreased sleep. Endorsed increased energy, racing thoughts, impulsive spending, and increased talkativeness. Symptoms reportedly occur together and have affected relationship functioning. Reviewed need for further mood assessment; no current SI/HI; plan to gather timeline and discuss psychiatry referral.”
From those clinician-entered details, AutoNotes can help create a structured draft that separates subjective report, objective observations, assessment considerations, and plan. The clinician can then revise the language to match the record, the client’s presentation, and the practice’s documentation standards.
Using AI support without losing clinical control
Assessment documentation requires careful wording. AI-assisted drafts can save time, but clinicians still need to verify accuracy, remove unsupported conclusions, and ensure the note reflects the actual session. This is especially true for screening tools like the MDQ, where the difference between “screening suggests further assessment” and “client has bipolar disorder” is clinically significant.
AutoNotes is designed to give clinicians a faster starting point, not to replace clinical judgment. A clinician can use it to reduce repetitive writing, keep note structure consistent, and document assessment-related care more clearly. The final decision about what belongs in the clinical record stays with the provider.
If MDQ-related documentation is taking too long after sessions, a structured AI-assisted draft can help you capture the key elements while they are still fresh: why the screen was used, what the client reported, how you followed up, and what the plan is.
Start your free trial to see how AutoNotes can help create editable clinical note drafts for assessment-related sessions, intake appointments, progress notes, and treatment planning.
References
- [source:1] Development and Validation of a Screening Instrument for Bipolar Spectrum Disorder: The Mood Disorder Questionnaire – PubMed
- [source:2] The Mood Disorder Questionnaire: A Simple, Patient-Rated Screening Instrument for Bipolar Disorder – PubMed
- [source:3] The Mood Disorder Questionnaire – Oregon Health & Science University
- [source:4] Bipolar Disorder – National Institute of Mental Health
- [source:6] Bipolar Disorders: Evaluation and Treatment – American Academy of Family Physicians
- [source:7] Bipolar Disorder: Assessment and Management – National Institute for Health and Care Excellence
